Updated: May 19, 2026

Alan L Crane

Pandion Therapeutics, Inc.SEC CIK: 0001294361
Estimated Net Worth
$13.8 Million
Last Updated: May 19, 2026 01:39 AM EST

Transaction Summary

Total Transactions42
Buy-Sell Ratio0.79
Buy Transactions15
Sell Transactions19

Transaction Volume

Total Volume$228.28M
Net Volume-$225.51M
Buy Volume$1.39M
Sell Volume$226.89M

Trade Analysis

AVG Trade Size$5.44M
Largest Trade$217.31M
Most Active MonthJun
Most Active Year2006

Trading Sentiment

OverallBearish
Recent TradeSelling
Last 90 Days0 Trades
ConvictionNone

Net Worth & Trading Activity Over Time

Loading chart

Monthly Trading Pattern

Loading chart

Past Insider Trading and Trends

Alan L Crane has an estimated net worth of $13.8 Million. This is based on reported shares across multiple companies, which include OCULAR THERAPEUTIX, INC, Cerulean Pharma Inc., Pandion Therapeutics Holdco LLC, T2 Biosystems, Inc., VACCINEX, INC., MOMENTA PHARMACEUTICALS INC, and Sirtris Pharmaceuticals, Inc..



2010 was Alan L Crane's most active year for acquiring shares with 4 total transactions. Alan L Crane's most active month to acquire stocks was the month of May. 2006 was Alan L Crane's most active year for disposing of shares, totalling 172 transactions. Alan L Crane's most active month to dispose stocks was the month of July. 2014 saw Alan L Crane paying a total of $330,000.00 for 46,000 shares, this is the most they've acquired in one year. In 2021 Alan L Crane cashed out on 98,155 shares for a total of $5,049,480.00, their largest year based on trade value.

Holdings & Transactions

Loading…
Loading…
Loading…
Loading…
Loading…
Loading…
Loading…